3 Stocks Trading for Way Less Than Their Recent Highs

Given their discounted stock prices, solid financials, and healthy growth prospects, I am bullish on these three TSX stocks.

| More on:
Value for money

Image source: Getty Images

After a challenging year, growth stocks have been back on investors’ radar amid signs of cooling inflation and the Federal Reserve slowing its interest rate hikes. Despite strong buying, the following three growth stocks trade at a substantial discount from their 52-week highs, thus offering an excellent buying opportunity for long-term investors.


Nuvei (TSX:NVEI) is a  global payments technology that facilitates business processing of next-gen payments. It operates in over 200 markets, supporting 150 currencies and 586 alternative payment methods (APMs). With the growth in e-commerce, more people are adopting digital payments, thus expanding the addressable market for Nuvei. Meanwhile, the company is strengthening its architecture and infrastructure, investing in developing innovative products, expanding its geographical reach, and adding new APMs to drive its market share.

Besides, Nuvei has signed an agreement to acquire Paya Holdings for US$1.3 billion. The acquisition could strengthen its position in the growing B2B (business-to-business) market. Further, the company has boosted its position in the United States online gaming industry through Maryland and Kansas gaming license wins. So, the payment solutions provider’s outlook looks healthy. However, despite its high growth prospects, the company trades at an over 55% discount from its 52-week high while its NTM (next 12 months) price-to-earnings stands at 17.1. Considering all these factors, I expect Nuvei to deliver oversized returns this year.

WELL Health Technologies

Second on my list would be WELL Health Technologies (TSX:WELL), which has gained over 47% since the beginning of this year. Despite the uptrend, it is still trading at a 26% discount compared to its 52-week high. Also, its NTM price-to-sales and NTM price-to-earnings multiples stand at 1.5 and 16.6, respectively, making it an attractive buy.

Meanwhile, WELL Health has continued to deliver solid financials, with its revenue and adjusted net income having grown by 47% and 51% in the November-ending quarter, respectively. Along with strategic acquisitions, strong performance from its virtual services segment drove its topline. Despite its acquisitions, the company has been maintaining its profitability, which is encouraging.

Meanwhile, I expect the uptrend to continue. The virtual healthcare market is growing amid the development of innovative products and increased internet penetration. With its acquisitions in the United States, the company is well-positioned to benefit from addressable market expansion.


Earlier this month, goeasy (TSX:GSY) reported impressive fourth-quarter performance, with loan originations of $632 million, representing 25% year-over-year growth. These loan originations expanded the company’s loan portfolio to $2.8 billion, up 29% from its previous year’s quarter. The lender’s net charge-off rate declined by 60 basis points from the fourth quarter of 2022 to 9%, within its target guidance of 8.5%–10.5%. Supported by these operational improvements, adjusted EPS (earnings per share) grew 11% year over year.

Meanwhile, goeasy continues to expand its product offerings, strengthen its distribution channels, and improve penetration to drive growth. The company’s management hopes to grow its loan portfolio by 79% to $5 billion by the end of 2025. The loan portfolio expansion could grow its revenue at a CAGR (compounded annual growth rate) of 18.5% while delivering a return on equity of over 22% annually.

Despite its healthy growth prospects, the company trades 14% lower than its 52-week high. Its NTM price-to-earnings also stands at 9.3, making it attractive at these levels.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nuvei. The Motley Fool has a disclosure policy.

More on Tech Stocks

Dividend Stocks

TFSA: 3 Value Stocks to Buy in April

The March dip is a synopsis of the mild recession banks anticipate as high interest rates trickles down. It is…

Read more »

Growing plant shoots on coins
Tech Stocks

Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now

If you've got $5,000 to invest, buying growth stocks like Lightspeed Commerce and Microsoft is a smart decision.

Read more »

edit Colleagues chat over ketchup chips
Tech Stocks

2 Easy TSX Stocks for Beginners in April 2023

You don’t need to think twice about loading up on these two Canadian stocks in April.

Read more »

calculate and analyze stock
Tech Stocks

Growth Stocks: A Once-in-a-Decade Opportunity to Get Rich

Growth stocks are generally cheap now. So, this year is a good opportunity to shop for growth stocks, perhaps through…

Read more »

grow money, wealth build
Tech Stocks

$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years

Growth stocks such as Dollarama and Chewy are well poised to deliver outsized gains to long-term investors.

Read more »

online shopping
Tech Stocks

Is Shopify Stock a Buy in March?

Shopify stock has had a volatile run, but fundamentals are strong, and valuations are much lower after its 71% decline.

Read more »

data analyze research
Tech Stocks

2 Top Stocks to Buy in March 2023

Given their solid financials and high-growth prospects, these two stocks are excellent buys right now.

Read more »

Male IT Specialist Holds Laptop and Discusses Work with Female Server Technician. They're Standing in Data Center, Rack Server Cabinet with Cloud Server Icon and Visualization
Tech Stocks

Is Kinaxis Stock a Buy at 52-Week Highs?

Kinaxis stock is up 31% in the last six months, though 5% in the last year. So as the stock…

Read more »